gene_symbol
UNKNOWN
binding_type
antigen recognition
cytotoxicity
YES
cytotoxicity_type
DIRECT
cytotoxicity_mechanism
Infused TILs recognize the EBV peptide–HLA class I complex via their native TCRs and directly kill target cells by releasing perforin and granzymes (with possible Fas/FasL-mediated apoptosis).
enzyme_product
Off
epitope
On
variant
Off
isoform
Off
hla_specific
On
gated
Off
other_modifier
Applicable in EBV-positive lymphomas (e.g., LMP/EBNA peptides bound to HLA-A/B/C)
trial_id_tar_ref
drug_id_tar_ref
disease_id_tar_ref
nct_id_tar_ref
NCT06541327
disease_id_num_tar_ref
5328
drug_id_num_tar_ref
14505